SPDR S&P Biotech ETF | 10-K: Annual report
SPDR S&P Biotech ETF | 4: Statement of changes in beneficial ownership of securities
SPDR S&P Biotech ETF | 4: Statement of changes in beneficial ownership of securities
SPDR S&P Biotech ETF | 4: Statement of changes in beneficial ownership of securities
SPDR S&P Biotech ETF | 4: Statement of changes in beneficial ownership of securities
SPDR S&P Biotech ETF | 4: Statement of changes in beneficial ownership of securities
SPDR S&P Biotech ETF | 4: Statement of changes in beneficial ownership of securities
SPDR S&P Biotech ETF | 10-Q: Quarterly report
SPDR S&P Biotech ETF | DEFA14A: Others
SPDR S&P Biotech ETF | DEF 14A: Definitive proxy statements
SPDR S&P Biotech ETF | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)
SPDR S&P Biotech ETF | 4: Statement of changes in beneficial ownership of securities
SPDR S&P Biotech ETF | 4: Statement of changes in beneficial ownership of securities
SPDR S&P Biotech ETF | 10-K: Annual report
SPDR S&P Biotech ETF | 4: Statement of changes in beneficial ownership of securities
SPDR S&P Biotech ETF | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
SPDR S&P Biotech ETF | 4: Statement of changes in beneficial ownership of securities
SPDR S&P Biotech ETF | 4: Statement of changes in beneficial ownership of securities
SPDR S&P Biotech ETF | 4: Statement of changes in beneficial ownership of securities
SPDR S&P Biotech ETF | 10-Q: Quarterly report